D. Méry-Mignard

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

Christophe Tournigand, Thierry André, Emmanuel Achille et al. · Journal of Clinical Oncology · 2003 · 2.9K citations · Full text

Medicine, Oncology, Pharmacology +13

FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

Christophe Tournigand, Thierry André, Emmanuel Achille et al. · Journal of Clinical Oncology · 2023 · 191 citations

Medicine, Oncology, Pharmacology +13

Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With Pharmacokinetics

Ernesto Wasserman, C. Cuvier, François Lokiec et al. · Journal of Clinical Oncology · 1999 · 134 citations

Medicine, Oncology, Pharmacology +17

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors

Marc Ychou, Thierry Conroy, Jean‐François Seitz et al. · Annals of Oncology · 2003 · 113 citations

Medicine, Oncology, Pharmacology +15

High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer

Frédérique Penault‐Llorca, R. Delva, Philippe Bougnoux et al. · Breast Cancer Research and Treatment · 2005 · 105 citations

Medicine, Oncology, Breast Oncology +16